Meense Viviana Matta
FDA investigator
Appears on 1 document from 2021, mostly at sites in Maryland. Most often cites control of microbiological contamination (21 CFR 211.113).
- 1
- Documents on file
- 3.0
- Observations per 483
- 2021
- First seen
- 2021
- Most recent
What they cite most
From 3 observations- 21 CFR 211.113Control of microbiological contamination1
- 21 CFR 211.192Production record review1
- 21 CFR 211.22Responsibilities of quality control unit1
Activity by year
2021: 1
Where
Maryland 1
Often inspects with
Is Meense Viviana Matta coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2021-03-19 | 483 AstraZeneca Pharmaceuticals LPMar 19, 2021 · Frederick, Maryland | Frederick, Maryland | 3 |
About this profile
What does Meense Viviana Matta inspect?
Meense Viviana Matta appears on 1 document on file covering 1 site, mostly in Maryland.
What do they cite most often?
21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.192 and 21 CFR 211.22.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Meense Viviana Matta is dated Mar 19, 2021.